Effects of beta-blockers on quality of life and well-being in patients with myocardial infarction and preserved left ventricular function—a prespecified substudy from REDUCE-AMI

Among patients after AMI with preserved left ventricular ejection fraction, self-reported quality of life and well-being was not significantly different in individuals randomized to routine long-term beta-blocker therapy as compared to individuals with no beta-blocker use. These results appear consistent regardless of adherence to randomized treatment and across subgroups which emphasizes the need for a careful individual risk-benefit evaluation prior to initiation of beta-blocker treatment.

Authors

Institutions

Publication Details

Journal
European Heart Journal - Cardiovascular Pharmacotherapy
Published
2024-09-01
DOI
https://doi.org/10.1093/ehjcvp/pvae062
Citations
9
Primary Topic
Cardiac, Anesthesia and Surgical Outcomes
Type
article
Field-Weighted Citation Impact
3.62

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Effects of beta-blockers on quality of life and well-being in patients with myocardial infarction and preserved left ventricular function—a prespecified substudy from REDUCE-AMI

Katarina Mars, Sophia Humphries, Jörg Lauermann, Joakim Alfredsson et al.
9 citations
European Heart Journal - Cardiovascular Pharmacotherapy
Cardiac, Anesthesia and Surgical Outcomes
3.62
article

Effects of beta-blockers on quality of life and well-being in patients with myocardial infarction and preserved left ventricular function—a prespecified substudy from REDUCE-AMI

Katarina Mars, Sophia Humphries, Jörg Lauermann, Joakim Alfredsson, Erik Olsson, Tomas Jernberg, Annica Ravn‐Fischer, Patric Karlström, Robin Hofmann, Martin N. Jonsson, Bertil Lindahl, Philip Leissner, Troels Yndigegn, David Erlinge, Claes Held, Thomas Kellerth
article en
9 citations

Abstract

Among patients after AMI with preserved left ventricular ejection fraction, self-reported quality of life and well-being was not significantly different in individuals randomized to routine long-term beta-blocker therapy as compared to individuals with no beta-blocker use. These results appear consistent regardless of adherence to randomized treatment and across subgroups which emphasizes the need for a careful individual risk-benefit evaluation prior to initiation of beta-blocker treatment.

European Heart Journal - Cardiovascular PharmacotherapyVol. 10(8)
Linköping University (SE), Uppsala University (SE), Lund University (SE), Sahlgrenska University Hospital (SE), Danderyds sjukhus (SE), Karolinska Institutet (SE), Stockholm South General Hospital (SE), Glanrhyd Hospital (GB), Karlstad Central Hospital (SE), Skåne University Hospital (SE), Ryhov Hospital Jönköping (SE), University of Gothenburg (SE)
Riksförbundet HjärtLung, Vetenskapsrådet
Good health and well-being
Openalex Percentile: Top 6%
Cardiac, Anesthesia and Surgical Outcomes
3.62
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.